Sodium Polystyrene Sulfonate

A to Z Drug Facts

Sodium Polystyrene Sulfonate

  Action
  Indications
  Contraindications
  Route/Dosage
  Interactions
  Lab Test Interferences
  Adverse Reactions
  Precautions
Patient Care Considerations
  Administration/Storage
  Assessment/Interventions
  Patient/Family Education


(SO-dee-uhm pah-lee-STYE-reen SULL-fuh-nate)
Kayexalate, Sodium Polystyrene Sulfonate, SPS
Class: Potassium-removing resin

 Action Resin that exchanges sodium ions for potassium in large intestine.

 Indications Treatment of hyperkalemia.

 Contraindications Hypokalemia.

 Route/Dosage

ADULTS: PO or via NG tube 15 g 1 to 4 times/day. PR 30 to 50 g q 6 hr has been given as daily enema. CHILDREN: PO Calculate children's dose by exchange ratio of 1 mEq potassium per gram of resin. (1 g/kg q 6 hr has been recommended.)

 Interactions

Digitalis: If hypokalemia occurs, likelihood of toxic effects of digoxin may be increased. Nonabsorbable cation donating antacids and laxatives (eg, aluminum carbonate, magnesium hydroxide): Systemic alkalosis has occurred. Potassium exchange capability of sodium polystyrene sulfonate may be reduced. Intestinal obstruction due to concretions of aluminum hydroxide when used in combination has occurred.

 Lab Test Interferences None well documented.

 Adverse Reactions

GI: Gastric irritation; anorexia; nausea; vomiting; constipation; fecal impaction. META: Hypokalemia; hypocalcemia; sodium retention.

 Precautions

Pregnancy: Category C. Lactation: Undetermined. Electrolyte abnormalities: Serious potassium deficiency can occur. Sodium polystyrene sulfonate is not totally selective for potassium and small amounts of magnesium and calcium can be lost. Use with caution in patients who cannot tolerate even small increase in sodium load (ie, severe congestive heart failure, severe hypertension, marked edema). Severe hyperkalemia: Treatment with this drug alone may be insufficient to rapidly correct severe hyperkalemia associated with states of rapid tissue breakdown (eg, burns, renal failure) or hyperkalemia so marked as to constitute medical emergency.


PATIENT CARE CONSIDERATIONS


 Administration/Storage

 Assessment/Interventions

OVERDOSAGE: SIGNS & SYMPTOMS
  Nausea, vomiting, constipation (fecal impaction), hypokalemia, hypocalcemia, sodium retention

 Patient/Family Education

Books@Ovid
Copyright
© 2003 Facts and Comparisons
David S. Tatro
A to Z Drug Facts